YANKCOM Partnership’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.53M Buy
19,566
+2,857
+17% +$230K 0.55% 39
2026
Q1
$1.45M Buy
16,709
+913
+6% +$87.5K 0.6% 43
2025
Q4
$1.52M Buy
15,796
+71
+0.5% +$6.9K 0.65% 37
2025
Q3
$1.5M Buy
15,725
+88
+0.6% +$8.09K 0.67% 35
2025
Q2
$1.36M Buy
15,637
+215
+1% +$18.2K 0.67% 36
2025
Q1
$1.39M Buy
15,422
+1,019
+7% +$91.2K 0.76% 34
2024
Q4
$1.15M Buy
+14,403
New +$1.25M 0.62% 42

Other funds holding MDT

YANKCOM Partnership's MDT Position: Q2 2026 in Review

YANKCOM Partnership increased its Medtronic (MDT) stake by 17% in Q2 2026, buying an estimated $230K and bringing the position to 19,566 shares worth $1.53M. The position accounts for 0.55% of the portfolio, ranked #39.

YANKCOM Partnership first reported a position in MDT in Q4 2024 and has held it in 7 quarters since. 1,271 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • YANKCOM Partnership held 19,566 shares of Medtronic worth $1.53M as of Q2 2026.
  • YANKCOM Partnership bought 2,857 Medtronic shares in Q2 2026, an estimated $230K.
  • Medtronic made up 0.55% of YANKCOM Partnership's portfolio in Q2 2026, its #39 holding.
  • YANKCOM Partnership first reported a position in Medtronic in Q4 2024 and has held it in 7 quarters since.
  • 1,271 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on YANKCOM Partnership's 13F filing for Q2 2026, filed 21 Jul 2026.